Lysosomal exoglycosidases and cathepsin D in colon adenocarcinoma

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 11, 2012, Pages 551-556

  Waszkiewicz, Napoleon ^a   Zalewska Szajda, Beata ^a   Szajda, Sławomir D ^a   Kȩpka, Alina ^b   Waszkiewicz, Magdalena ^c   Roszkowska Jakimiec, Wiesława ^a   Wojewódzka Zeleźniakowicz, Marzena ^a   Milewska, Anna J ^a   Dadan, Jacek ^a   Szulc, Agata ^a   Zwierz, Krzysztof ^d   Ładny, Jerzy R ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c Regional Hospital in Bialystok   (Poland)

^d Medical College of the Universal Education Society   (Poland)

Author keywords

Cathepsin D; Colon adenocarcinoma; Lysosomal exoglycosidases

Indexed keywords

ALPHA LEVO FUCOSIDASE; ALPHA MANNOSIDASE; BETA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE; BETA N ACETYLHEXOSAMINIDASE A; BETA N ACETYLHEXOSAMINIDASE B; CATHEPSIN D; EXOGLYCOSIDASE; LYSOSOME ENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER TISSUE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; MALE; PROTEIN URINE LEVEL; TISSUE LEVEL; URINALYSIS;

EID: 84872351274     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1462     Document Type: Article

References (52)

1. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007; 18: 581-592.
2. Szajda SD, Jankowska A, Zwierz K. Carbohydrate markers in colon carcinoma. Dis Markers. 2008; 25: 233-242.
3. Groblewska M, Mroczko B, Szmitkowski M. [The role of matrix metalloproteinases selected and Their inhibitors in colorectal cancer sevelopment]. Postepy Hig Med Dosw (Online). 2010; 64: 22-30. Polish.
4. Liotta LA, Rao CN, Wewer UM. Biochemical interactions of tumor cells with basement membrane. Ann Rev Biochem. 1986; 55: 1037-1057.
5. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell. 1992; 69: 11-25.
6. Moszczyński P, Lisiewicz J. Deficiency of N-acetyl-beta-D- glucosaminidase in neutrophils of cancer patients. J Cancer Res Clin Oncol. 1984; 108: 243-245.
7. Sułowicz W, Lisiewicz J, Kuźniewski M, Strzałka H. Activity of some lysosomal enzymes in peripheral blood lymphocytes of patients with lung cancer. A cytochemical study. Folia Haematol Int Mag Klin Morphol Blutforsch. 1985; 112: 63-70.
8. Winchester B. Lysosomal metabolism of glycoproteins. Glycobiology. 2005; 15: 1R-15R.
9. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997; 89: 1260-1270.
10. Tomaszewski JJ, Tomaszewski T. [Lytic enzymes in tumor proliferation]. Diagn Lab. 1991; 27: 56-62. Polish.
11. Davies DR. The structure and function of the aspartic proteinases. Ann Rev Biophys Chem. 1990; 19: 189-215.
12. Nagata S. Apoptosis by death factor. Cell. 1997; 88: 355-365.
13. Garcia M, Derocq D, Pujol P, Rochefort H. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene. 1990; 5: 1809-1814.
14. Zwierz K, Zalewska A, Zoch-Zwierz W. Isoenzymes of N-acetyl-beta- hexosaminidase. Acta Biochim Polon. 1999; 46: 739-751.
15. Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. Cancer. 4th ed. Garland Science, New York; 2002: 1313-1362.
16. Waszkiewicz N, Szajda SD, Konarzewska B, et al. Underappreciated role of binge drinking in the risk of lung cancer. Eur J Public Health. 2010; 20: 6.
17. Waszkiewicz N, Szajda SD, Jankowska A, et al. Catabolism of salivary glycoconjugates in acute ethanol intoxication. Med Sci Monit. 2009; 15: CR413-CR417.
18. Waszkiewicz N, Szajda SD, Kȩpka A, et al. Glycoconjugates in the detection of alcohol abuse. Biochem Soc Trans. 2011; 39: 365-369.
19. Waszkiewicz N, Szajda SD, Zalewska A, et al. Alcohol abuse and glycoconjugate metabolism. Folia Histochem Cytobiol. 2012; 50: 1-11.
20. Zwierz K, Gindzieński A, Ostrowska L, et al. Metabolism of glycoconjugates in human gastric mucosa: a review. Acta Med Hung. 1989; 46: 275-288.
21. Gacko M, Zwierz K, Arciuch L, et al. Activity of exoglycosidases in the aneurysmal aortic wall. Vasc Surg. 1998; 32: 349-352.
22. Szajda SD, Snarska J, Puchalski Z, Zwierz K. Lysosomal exoglycosidases in serum and urine of patients with colon adenocarcinoma. Hepatogastroenterology. 2008; 55: 921-925.
23. Szajda SD, Borzym-Kluczyk M, Snarska J, et al. N-acetyl-beta-D- hexosaminidase and its isoenzymes A and B in blood serum and urine, as a potential colon cancer markers. Hepatogastroenterology. 2009; 56: 1287-1298.
24. Szajda SD, Snarska J, Jankowska A, et al. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. Hepatogastroenterology. 2008; 55: 388-393.
25. Szajda SD, Roszkowska-Jakimiec W, Snarska J, et al. [Cathepsin D activity in the blood serum and urine in patients with colonic adenocarcinoma]. Współczesna Onkologia. 2006; 10: 321-323. Polish.
26. Kjellmo A, Drolsum A. [Diagnosis and staging of colorectal cancer]. Tidsskr Nor Laegeforen. 2007; 127: 2824-2828. Norwegian.
27. Marciniak J, Zalewska A, Popko J, et al. Optimization of an enzymatic method for the determination of lysosomal N-acetyl-beta-D-hexosaminidase and beta-glucuronidase in synovial fluid. Clin Chem Lab Med. 2006; 44: 933-937.
28. Folin O, Ciocalteau V. On tyrosine and tryptophane determinations in proteins. J Biol Chem. 1927; 73: 627-650.
29. Greczaniuk A, Roszkowska-Jakimiec W, Worowska A, et al. [Influence of exogenous chemical compounds on blood plasma cathepsin D activity]. Diagn Lab. 2001; 37: 499-503. Polish.
30. Lowry OH, Rosebrought NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193: 265-275.
31. Szajda SD, Waszkiewicz N, Chojnowska S, Zwierz K. Carbohydrate markers of pancreatic cancer. Biochem Soc Trans. 2011; 39: 340-343.
32. Wielgat P, Walczuk U, Szajda S, et al. Activity of lysosomal exoglycosidases in human gliomas. J Neurooncol. 2006; 80: 243-249.
33. Borzym-Kluczyk M, Radziejewska I, Olszewska E, et al. Statistical evaluation of the isoform patterns of N-acetyl-beta-hexosaminidase from human renal cancer tissue separated by isoelectrofocusing. Clin Biochem. 2007; 4: 403-406.
34. Szajda SD, Snarska J, Jankowska A, et al. Isoenzymes A and B of N-acetyl-beta-D-hexosaminidase in serum and urine of patients with pancreatic cancer. Hepatogastroenterology. 2008; 55: 695-698.
35. Szajda SD, Waszkiewicz N, Stypułkowska A, et al. Lysosmal exoglycosidases in serum and urine of patients with pancreatic adenocarcinoma. Folia Histochem Cytobiol. 2010; 48: 351-357.
36. Szajda SD, Zalewska B, Michalak K, et al. [Cathepsin D activity in cases of uterine leiomyoma]. Współczesna Onkologia. 2004; 5: 266-268. Polish.
37. Gonzalez-Vela MC, Garijo MF, Fernandez F, et al. Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma. Histopathology. 1999; 34: 35-42.
38. Szajda SD, Jankowski M, Zalewska B, et al. [Activity of cancer procoagulant and cathepsin D in breast cancer]. Współczesna Onkologia. 2004; 8: 132-135. Polish.
39. Kristensen GB, Holm R, Abeler VM, Tropé CG. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study. Cancer. 1996; 78: 433-440.
40. Lösch A, Kohlberger P, Gitsch G, et al. Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. Br J Cancer. 1996; 73: 1525-1528.
41. Moul JW, Maygarden SJ, Ware JL, et al. Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy. J Urol. 1996; 155: 982-985.
42. Sivaparvathi M, Sawaya R, Chintala SK, et al. Expression of cathepsin D during the progression of human gliomas. Neurosci Lett. 1996; 208: 171-174.
43. Metaye T, Kraimps JL, Goujon JM, et al. Expression, localization, and thyrotropin regulation of cathepsin D in human thyroid tissues. J Clin Endocrinol Metab. 1997; 82: 3383-3388.
44. Seiwerth S, Stambuk N, Konjevoda P, et al. Immunohistochemical analysis and prognostic value of cathepsin D determination in laryngeal squamous cell carcinoma. J Chem Inf Compust Sci. 2000; 40: 545-549.
45. Leto G, Tumminello FM, Pizzolanti G, et al. Cathepsin D serum mass concentrations in patients with hepatocellular carcinoma and/or liver cirrhosis. Eur J Clin Chem Clin Biochem. 1996; 34: 555-560.
46. Russo A, Bazan V, Migliavacca M, et al. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma. Clin Cancer Res. 2000; 6: 178-184.
47. Arao J, Fukui H, Ono Y, et al. Immunohistochemical localization of cathepsin D in colorectal tumors. Dis Colon Rectum. 2000; 43: 396-401.
48. Bartenjev I, Rudolf Z, Stabuc B, et al. Cathepsin D expression in early cutaneous malignant melanoma. Int J Dermatol. 2000; 39: 599-602.
49. Strojan P, Budihna M, Smid L, et al. Cathepsin D in tissue and serum of patients with squamous cell carcinoma of head and neck. Cancer Lett. 1998; 130: 49-56.
50. Wigmore SJ, McMahon AJ, Sturgeon CM, Fearon KC. Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg. 2001; 88: 255-260.
51. Olszewska E, Borzym-Kluczyk M, Olszewski S, et al. Hexosaminidase as a new potential marker for middle ear cholesteatoma. Clin Biochem. 2006; 39: 1088-1090.
52. Wasilewicz MP, Kołodziej B, Bojułko T, et al. Expression of cyclooxygenase-2 in colonic polyps. Pol Arch Med Wewn. 2010; 120: 313-320.